| 1 |
34365852 | Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. | 2022 Feb |
1 |
| 2 |
34913340 | Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers. | 2022 Jan 10 |
1 |
| 3 |
33536280 | Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. | 2021 Feb 3 |
2 |
| 4 |
33741008 | A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy. | 2021 Mar 19 |
1 |
| 5 |
34440055 | Development and Characterization of a Novel Peptide-Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors. | 2021 Jul 21 |
1 |
| 6 |
32570117 | T-DM1-induced thrombocytopenia in breast cancer patients: New perspectives. | 2020 Sep |
1 |
| 7 |
33371333 | Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy. | 2020 Dec 21 |
1 |
| 8 |
31318460 | Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE. | 2019 Nov 15 |
1 |
| 9 |
29456473 | Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients. | 2017 Dec |
2 |
| 10 |
24308017 | Trastuzumab emtansine for the treatment of HER2-positive metastatic breast cancer. | 2013 Nov |
1 |
| 11 |
22475266 | Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer. | 2012 Sep 1 |
2 |